Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01026532 · ClinicalTrials.gov registry record
Functional Activity of Airway Eosinophils in Allergic Disease
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 31
- Enrollment target
NCT01026532: Completed study, sponsored by University of Wisconsin, Madison.
NCT01026532 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01026532 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 31 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how a special white blood cell, the eosinophil, can contribute to asthma. One of the characteristics of asthma is airway inflammation. Airway inflammation in asthma may occur when an allergen is inhaled and sets up an allergic reaction in the bronchial tubes. This reaction may lead to chest tightness, cough and wheeze. To better understand the way in which the eosinophil can cause inflammation, the investigators plan to study eosinophils that move in to the lung following an allergic reaction.
Primary Outcome
Measurement taken at 48 hours after segmental antigen challenge.
Interventions
- BIOLOGICAL Segmental Allergen Challenge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2011-08-24 |
| Est. Completion | 2017-03-31 |
What the finished NCT01026532 record still lists
NCT01026532 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 31 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Segmental Allergen Challenge is the first listed.
NCT01026532 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01026532 about?
NCT01026532 is a clinical study titled "Functional Activity of Airway Eosinophils in Allergic Disease". The purpose of this study is to determine how a special white blood cell, the eosinophil, can contribute to asthma. One of the characteristics of asthma is airway inflammation. Airway inflammation in asthma may occur when an allergen is inhaled and sets up an allergic reaction in the bronchial tubes...
What is the current status of trial NCT01026532?
This trial is currently completed. The enrollment target is 31 participants. The study started on 2011-08-24. Estimated completion is 2017-03-31.
What interventions are being tested in trial NCT01026532?
The interventions under investigation include: Segmental Allergen Challenge (BIOLOGICAL).
Who is sponsoring clinical trial NCT01026532?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI